Lee Hambright

Stock Analyst at Bernstein

(1.41)
# 3,677
Out of 5,124 analysts
201
Total ratings
53%
Success rate
-0.4%
Average return

Stocks Rated by Lee Hambright

Edwards Lifesciences
Nov 5, 2026
Reiterated: Hold
Price Target: $106
Current: $104.71
Upside: +1.23%
Medline
Nov 5, 2026
Reiterated: Buy
Price Target: $54 → $49
Current: $40.71
Upside: +20.36%
Insulet
Nov 5, 2026
Rated: Buy
Price Target: $175 → $200
Current: $149.81
Upside: +33.50%
Zimmer Biomet Holdings
Nov 5, 2026
Rated: Hold
Price Target: $93 → $107
Current: $108.33
Upside: -1.23%
Boston Scientific
Oct 29, 2026
Reiterated: Buy
Price Target: $54 → $49
Current: $44.02
Upside: +11.31%
Intuitive Surgical
Oct 21, 2026
Reiterated: Buy
Price Target: $685
Current: $460.56
Upside: +48.73%
Johnson & Johnson
Oct 14, 2026
Reiterated: Hold
Price Target: $270
Current: $282.11
Upside: -4.29%
Medtronic
Jun 4, 2026
Reiterated: Buy
Price Target: $112 → $97
Current: $102.79
Upside: -5.63%
DexCom
May 15, 2026
Reiterated: Buy
Price Target: $77
Current: $81.07
Upside: -5.02%
Stryker
May 1, 2026
Reiterated: Buy
Price Target: $465 → $410
Current: $325.73
Upside: +25.87%
Reiterated: Buy
Price Target: $154 → $125
Current: $110.51
Upside: +13.11%
Reiterated: Hold
Price Target: n/a
Current: $18.17
Upside: -